| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.46B | 40.55B | 55.38B | 39.73B | 29.55B | 30.29B |
| Gross Profit | 4.25B | 4.25B | 4.23B | 3.99B | 4.88B | 3.72B |
| EBITDA | 3.53B | 3.36B | 1.77B | 1.23B | 2.38B | 1.41B |
| Net Income | 1.25B | 1.27B | 625.00M | 328.00M | 1.34B | 776.00M |
Balance Sheet | ||||||
| Total Assets | 64.50B | 69.32B | 76.83B | 61.13B | 52.53B | 49.94B |
| Cash, Cash Equivalents and Short-Term Investments | 9.12B | 10.32B | 6.59B | 7.88B | 12.34B | 8.93B |
| Total Debt | 14.99B | 19.35B | 21.28B | 12.22B | 9.00B | 9.97B |
| Total Liabilities | 32.61B | 37.49B | 43.76B | 31.27B | 22.98B | 21.91B |
| Stockholders Equity | 31.88B | 31.83B | 32.53B | 29.38B | 29.12B | 27.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.73B | -9.72B | -7.60B | 4.61B | 2.70B |
| Operating Cash Flow | 0.00 | 8.18B | -8.58B | -6.50B | 4.82B | 3.49B |
| Investing Cash Flow | 0.00 | -869.00M | -146.00M | -643.00M | 37.00M | -2.52B |
| Financing Cash Flow | 0.00 | -3.59B | 7.43B | 2.68B | -1.45B | -686.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥163.43B | 18.30 | ― | 5.06% | 12.80% | 34.19% | |
73 Outperform | ¥334.46B | 13.08 | ― | 3.17% | 16.62% | 42.69% | |
72 Outperform | ¥8.68B | 6.96 | ― | 3.76% | -32.18% | 39.56% | |
70 Outperform | ¥103.65B | 16.55 | ― | 2.47% | 6.90% | -25.24% | |
70 Outperform | ¥210.85B | 13.21 | ― | 4.15% | -3.72% | 59.02% | |
63 Neutral | ¥111.60B | 13.85 | ― | 3.47% | 20.38% | 128.85% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |